Template:Drugs for functional gastrointestinal disorders: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import Tags: mobile edit mobile web edit |
en>Whywhenwhohow add entries; sort |
||
| Line 5: | Line 5: | ||
|listclass = hlist | |listclass = hlist | ||
| group1 = Drugs for<br/> [[ | | group1 = Drugs for<br/> [[Functional gastrointestinal disorder|functional<br/> bowel <br>disorders]] | ||
| list1 = {{Navbox|subgroup | | list1 = {{Navbox|subgroup | ||
| Line 13: | Line 13: | ||
| group1 = Tertiary<br/> amino group | | group1 = Tertiary<br/> amino group | ||
| list1 = | | list1 = | ||
* [[Camylofin]] | * [[Camylofin]] | ||
* [[Dicycloverine]] | * [[Dicycloverine]] | ||
* [[Difemerine]] | |||
* [[Dihexyverine]] | * [[Dihexyverine]] | ||
* [[ | * [[Mebeverine]] | ||
* [[Oxyphencyclimine]] | |||
* [[Piperidolate]] | * [[Piperidolate]] | ||
* [[Rociverine]] | |||
* [[Trimebutine]] | |||
| group2 = [[Quaternary ammonium|Quaternary<br/> ammonium]]<br/> compounds | | group2 = [[Quaternary ammonium|Quaternary<br/> ammonium]]<br/> compounds | ||
| list2 = | | list2 = | ||
* [[Benzilone]] | * [[Benzilone]] | ||
* [[Bevonium]] | |||
* [[Diphemanil metilsulfate|Diphemanil]] | |||
* [[Fenpiverinium]] | |||
* [[Glycopyrronium bromide|Glycopyrronium]] | |||
* [[Hexocyclium]] | |||
* [[Isopropamide]] | |||
* [[Mepenzolate]] | * [[Mepenzolate]] | ||
* [[ | * [[Methantheline]] | ||
* [[ | * [[Otilonium bromide|Otilonium]] | ||
* [[Oxyphenonium bromide|Oxyphenonium]] | * [[Oxyphenonium bromide|Oxyphenonium]] | ||
* [[Penthienate]] | * [[Penthienate]] | ||
* [[ | * [[Pipenzolate]] | ||
* [[Poldine]] | |||
* [[Prifinium bromide|Prifinium]] | |||
* [[Propantheline]] | * [[Propantheline]] | ||
* [[Tiemonium iodide|Tiemonium]] | * [[Tiemonium iodide|Tiemonium]] | ||
* [[Timepidium bromide|Timepidium]] | * [[Timepidium bromide|Timepidium]] | ||
* [[ | * [[Tridihexethyl]] | ||
}} | }} | ||
| Line 49: | Line 49: | ||
| group2 = [[Phosphodiesterase inhibitor|Phosphodiesterase<br/> inhibitors]] | | group2 = [[Phosphodiesterase inhibitor|Phosphodiesterase<br/> inhibitors]] | ||
| list2 = | | list2 = | ||
* [[Drotaverine]] | * [[Drotaverine]] | ||
* [[Moxaverine]] | * [[Moxaverine]] | ||
* [[Papaverine]] | |||
| group3 = Acting on<br/> [[5-HT receptor|serotonin receptors]] | | group3 = Acting on<br/> [[5-HT receptor|serotonin receptors]] | ||
| Line 68: | Line 68: | ||
* [[Diisopromine]] | * [[Diisopromine]] | ||
* [[Dimethylaminopropionylphenothiazine]] | * [[Dimethylaminopropionylphenothiazine]] | ||
* [[Fenoverine]] | |||
* [[Fenpiprane]] | * [[Fenpiprane]] | ||
* [[Idanpramine]] | * [[Idanpramine]] | ||
* [[Isometheptene]] | * [[Isometheptene]] | ||
* [[Mentha piperita]] | |||
* [[Phloroglucinol]] | * [[Phloroglucinol]] | ||
* [[Pinaverium bromide]] | * [[Pinaverium bromide]] | ||
* [[Proxazole]] | * [[Proxazole]] | ||
* [[ | * [[Simeticone]] | ||
* [[Tiropramide]] | * [[Tiropramide]] | ||
* [[Trepibutone]] | * [[Trepibutone]] | ||
| Line 87: | Line 88: | ||
* [[Hyoscyamine]] | * [[Hyoscyamine]] | ||
*''Quaternary ammonium compounds:'' | *''Quaternary ammonium compounds:'' | ||
**[[Hyoscine hydrobromide|Scopolamine]] | **[[Hyoscine hydrobromide|Scopolamine]] | ||
** [[Butylscopolamine]] | ** [[Butylscopolamine]] | ||
** [[Methylscopolamine bromide|Methylscopolamine]] | ** [[Methylscopolamine bromide|Methylscopolamine]] | ||
* [[Cimetropium bromide]] | |||
* [[Fentonium bromide]] | |||
* [[Methylatropine]] | * [[Methylatropine]] | ||
| group3 = [[Prokinetic|Propulsive]]s | | group3 = [[Prokinetic|Propulsive]]s | ||
| list3 = | | list3 = | ||
* ''[[dopamine antagonist|Primarily dopamine antagonists]]'' | * ''[[dopamine antagonist|Primarily dopamine antagonists]]'' | ||
** [[ | ** [[Alizapride]] | ||
** [[Bromopride]] | |||
** [[Clebopride]] | ** [[Clebopride]] | ||
** [[Domperidone]] | ** [[Domperidone]] | ||
** [[ | ** [[Metoclopramide]] | ||
* ''[[Serotonin receptor agonist|5-HT<sub>4</sub> agonist]]s'' | * ''[[Serotonin receptor agonist|5-HT<sub>4</sub> agonist]]s'' | ||
** [[Cinitapride]] | ** [[Cinitapride]] | ||
** [[Cisapride]] | ** [[Cisapride]] | ||
* [[Acotiamide]] | |||
* [[Ilebopride]] | |||
* [[Mosapride]] | |||
}}<noinclude> | }}<noinclude> | ||
| Line 111: | Line 116: | ||
[[Category:Drug_templates by ATC]] | [[Category:Drug_templates by ATC]] | ||
</noinclude> | </noinclude> | ||
Revision as of 03:30, 10 June 2024
| Drugs for functional gastrointestinal disorders (A03) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
